Exscientia

About

Recursion is a clinical-stage technology company applying artificial intelligence to drug discovery and development. Their Recursion OS platform integrates extensive biological and chemical datasets – exceeding 65 petabytes – with automated experimentation and machine learning to rapidly identify drug candidates and optimize molecule design. Targeting conditions with high unmet need like cancer and rare diseases, Recursion aims to significantly improve the efficiency and reduce the failure rate traditionally associated with pharmaceutical research.

Focus Areas

Technology Focus